NASDAQ, INC.

NDAQ

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Eventide Asset Management

AI Signal

**SIGNAL NOTE: Eventide initiation in NDAQ** This $68.8M position in Nasdaq Inc.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Eventide Asset ManagementNEWFeb 13, 2026

Shares: 707,048Value: $68.8M

**SIGNAL NOTE: Eventide initiation in NDAQ** This $68.8M position in Nasdaq Inc. (the exchange operator) is a significant departure from Eventide's biotech-focused mandate and suggests conviction in market infrastructure plays rather than therapeutics exposure. The timing coincides with elevated biotech IPO/SPAC activity and potential regulatory tailwinds, though this represents portfolio diversification rather than a direct drug/indication bet.

More NDAQ Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

CPRT1 fund DECK1 fund LITE1 fund NTAP1 fund GPI1 fund IMMX1 fund PI1 fund UNP1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: